95 related articles for article (PubMed ID: 17602685)
1. Pathologic evaluation of uterine leiomyoma treated with radiofrequency ablation.
Luo X; Shen Y; Song WX; Chen PW; Xie XM; Wang XY
Int J Gynaecol Obstet; 2007 Oct; 99(1):9-13. PubMed ID: 17602685
[TBL] [Abstract][Full Text] [Related]
2. The Research of Feasibility and Efficacy of Radiofrequency Ablation in Treating Uterine Fibroids.
Luo X; Shu SR; Ma XF; Shuai HL
Medicine (Baltimore); 2015 Nov; 94(47):e1956. PubMed ID: 26632689
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 14-3-3 protein family levels and associated receptor expression of estrogen and progesterone in human uterine leiomyomas.
Wang L; Huang H; Liu D; Fang S; Xian Y; Zhou J; Zuo Y; Wang F; Huang O; He M
Gynecol Endocrinol; 2012 Aug; 28(8):665-8. PubMed ID: 22329840
[TBL] [Abstract][Full Text] [Related]
5. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
[TBL] [Abstract][Full Text] [Related]
6. [Research on the relationship between estrogen receptor, progesterone receptor, cell proliferation associated antigen in uterine leiomyoma and nuclear body density of myoma, serum reproductive hormone concentrations].
Wu J; Cheng Y
Zhonghua Fu Chan Ke Za Zhi; 1995 Oct; 30(10):603-7. PubMed ID: 8745507
[TBL] [Abstract][Full Text] [Related]
7. Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas.
Vu K; Greenspan DL; Wu TC; Zacur HA; Kurman RJ
Hum Pathol; 1998 Apr; 29(4):359-63. PubMed ID: 9563785
[TBL] [Abstract][Full Text] [Related]
8. Uterine Leiomyomas: Safety and Efficacy of US-guided Suprapubic Transvaginal Radiofrequency Ablation at 1-year Follow-up.
Wu XJ; Guo Q; Cao BS; Tan LX; Zhang HY; Cai YR; Gao BL
Radiology; 2016 Jun; 279(3):952-60. PubMed ID: 26694049
[TBL] [Abstract][Full Text] [Related]
9. Correlation between the growth of uterine leiomyomata and estrogen and progesterone receptor content in needle biopsy specimens.
Ichimura T; Kawamura N; Ito F; Shibata S; Minakuchi K; Tsujimura A; Umesaki N; Ogita S
Fertil Steril; 1998 Nov; 70(5):967-71. PubMed ID: 9806586
[TBL] [Abstract][Full Text] [Related]
10. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
[TBL] [Abstract][Full Text] [Related]
11. [Effects of mifepristone on estrogen and progestin receptors in human uterine leiomyoma].
Wang H; Jin J
Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):79-81. PubMed ID: 11809103
[TBL] [Abstract][Full Text] [Related]
12. Treatment effects of GnRH agonist on the binding of estrogen and progesterone, and the histological findings of uterine leiomyomas.
Uemura T; Mori J; Yoshimura Y; Minaguchi H
Asia Oceania J Obstet Gynaecol; 1991 Dec; 17(4):315-20. PubMed ID: 1724899
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
Maleeva A; Milkov V
Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and progesterone receptors expression in gastrointestinal stromal tumors and intramural gastrointestinal leiomyomas.
Brodsky SV; Gimenez C; Ghosh C; Melamed M; Ramaswamy G
Int J Gastrointest Cancer; 2006; 37(4):129-32. PubMed ID: 17992477
[TBL] [Abstract][Full Text] [Related]
15. Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas.
Khan KN; Fujishita A; Koshiba A; Ogawa K; Mori T; Ogi H; Itoh K; Teramukai S; Kitawaki J
PLoS One; 2020; 15(11):e0242246. PubMed ID: 33186388
[TBL] [Abstract][Full Text] [Related]
16. Clinical correlates of leiomyoma estrogen and progesterone receptors among Nigerian women.
Awowole IO; Makinde ON; Badejoko OO; Omoniyi-Esan GO; Tijani AM; Ajenifuja KO; Loto OM
Int J Gynaecol Obstet; 2016 Dec; 135(3):314-318. PubMed ID: 27599599
[TBL] [Abstract][Full Text] [Related]
17. Effects of gestrinone on uterine leiomyoma and expression of c-Src in a guinea pig model.
Zhu Y; Qiu XY; Wang L; Wu JH; Liu GM; He GL; Jiang XR; Sun ZY; Cao L
Acta Pharmacol Sin; 2007 May; 28(5):685-94. PubMed ID: 17439725
[TBL] [Abstract][Full Text] [Related]
18. Expression of progesterone receptor form A and B mRNAs in uterine leiomyoma.
Fujimoto J; Hirose R; Ichigo S; Sakaguchi H; Li Y; Tamaya T
Tumour Biol; 1998; 19(2):126-31. PubMed ID: 9486564
[TBL] [Abstract][Full Text] [Related]
19. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
20. Comparing regulation of the connexin43 gene by estrogen in uterine leiomyoma and pregnancy myometrium.
Andersen J
Environ Health Perspect; 2000 Oct; 108 Suppl 5():811-5. PubMed ID: 11035987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
